Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
On October 7, 2010, Dr. Mama Fouda of the Cameroonian Ministry of Public Health, approved the creation of the National Immunization Trust Fund (NITF) as an alternative for sustainable immunization financing in Cameroon.
Things seem to be moving in the right direction for immunization financing in the DRC. After sponsoring and actively participating in a very successful parliamentary briefing a few months ago, we have recently organized the first SIF Sabin sponsored peer exchange for the DRC.
On 28 September, seventeen parliamentarians and government officials came together in Bamako to discuss ways to sustainably finance Mali’s immunization program. It was the latest in a series of Sabin-organized briefings that began in Bamako in October 2009.